FDA Revisits Rare Cancer Drug Approval After Unexpected Rejection Sparks Controversy
The FDA is reconsidering its decision to reject a treatment for a rare cancer after an unexpected rejection. Meanwhile, experts question the Trump adm...
The FDA is reconsidering its decision to reject a treatment for a rare cancer after an unexpected rejection. Meanwhile, experts question the Trump adm...
In 2019, systems biologist Sebastiaan van Heesch uncovered hundreds of previously unknown mini-proteins in human heart tissue using ribosome profiling...